Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett A King

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Journal of the American Academy of Dermatology|September 6, 2020
Ultraviolet light in combination with other therapies for vitiligo: Synergy or necessity?Danielle Peterson, Brett A King
JAMA Dermatology|January 24, 2019
Targeted Treatment of TREX1 Chilblain Lupus and Other Interferonopathies-Taming T REXWilliam Damsky, Brett A King
JAAD Case Reports|January 8, 2020
Treatment of granuloma annulare with tofacitinib 2% ointmentWilliam Damsky, Brett A King
JAAD Case Reports|December 23, 2016
Idiopathic erythema multiforme: Evidence of underlying Janus kinase-signal transducer and activator of transcription activation and successful treatment with tofacitinibWilliam Damsky, Brett A King
Journal of the American Academy of Dermatology|February 1, 2017
JAK inhibitors in dermatology: The promise of a new drug classWilliam Damsky, Brett A King
JAMA Dermatology|December 3, 2015
Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia UniversalisArjun Dhayalan, Brett A King
JAAD Case Reports|December 15, 2020
Gut instinct: Using tofacitinib to treat alopecia areata in the context of comorbid inflammatory bowel diseaseDanielle M Peterson, Brett A King
Journal of the American Academy of Dermatology|April 10, 2022
Reply to: "Special editorial: When prescribing Janus Kinase inhibitors for dermatologic conditions, be mindful of the Food and Drug Administration's September 1, 2021, data safety communication"Brett A King, Brittany G Craiglow
Journal of the American Academy of Dermatology|August 17, 2023
Janus kinase inhibitors for alopecia areataBrett A King, Brittany G Craiglow
Archives of Dermatology|November 23, 2011
Neglected squamous cell carcinoma hiding under a toupeeBrittany G Craiglow, Brett A King
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Journal of the American Academy of Dermatology|September 6, 2020
Ultraviolet light in combination with other therapies for vitiligo: Synergy or necessity?Danielle Peterson, Brett A King
JAMA Dermatology|January 24, 2019
Targeted Treatment of TREX1 Chilblain Lupus and Other Interferonopathies-Taming T REXWilliam Damsky, Brett A King
JAAD Case Reports|January 8, 2020
Treatment of granuloma annulare with tofacitinib 2% ointmentWilliam Damsky, Brett A King
JAAD Case Reports|December 23, 2016
Idiopathic erythema multiforme: Evidence of underlying Janus kinase-signal transducer and activator of transcription activation and successful treatment with tofacitinibWilliam Damsky, Brett A King
Journal of the American Academy of Dermatology|February 1, 2017
JAK inhibitors in dermatology: The promise of a new drug classWilliam Damsky, Brett A King
JAMA Dermatology|December 3, 2015
Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia UniversalisArjun Dhayalan, Brett A King
JAAD Case Reports|December 15, 2020
Gut instinct: Using tofacitinib to treat alopecia areata in the context of comorbid inflammatory bowel diseaseDanielle M Peterson, Brett A King
Journal of the American Academy of Dermatology|April 10, 2022
Reply to: "Special editorial: When prescribing Janus Kinase inhibitors for dermatologic conditions, be mindful of the Food and Drug Administration's September 1, 2021, data safety communication"Brett A King, Brittany G Craiglow
Journal of the American Academy of Dermatology|August 17, 2023
Janus kinase inhibitors for alopecia areataBrett A King, Brittany G Craiglow
Archives of Dermatology|November 23, 2011
Neglected squamous cell carcinoma hiding under a toupeeBrittany G Craiglow, Brett A King
Pageof 7